Novo Nordisk A/S (NVO)
46.94
+0.20
(+0.44%)
USD |
NYSE |
Aug 24, 16:00
47.05
+0.10
(+0.22%)
After-Hours: 20:00
Novo Nordisk Total Liabilities (Quarterly) : 57.15B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 57.15B |
| March 31, 2026 | 54.92B |
| December 31, 2025 | 54.85B |
| September 30, 2025 | 53.90B |
| June 30, 2025 | 49.42B |
| March 31, 2025 | 50.77B |
| December 31, 2024 | 44.76B |
| September 30, 2024 | 41.46B |
| June 30, 2024 | 36.91B |
| March 31, 2024 | 28.96B |
| December 31, 2023 | 30.81B |
| September 30, 2023 | 29.41B |
| June 30, 2023 | 27.88B |
| March 31, 2023 | 24.82B |
| December 31, 2022 | 22.64B |
| September 30, 2022 | 21.89B |
| June 30, 2022 | 20.31B |
| March 31, 2022 | 19.53B |
| December 31, 2021 | 18.92B |
| September 30, 2021 | 16.83B |
| June 30, 2021 | 14.76B |
| March 31, 2021 | 13.10B |
| December 31, 2020 | 13.41B |
| September 30, 2020 | 12.66B |
| June 30, 2020 | 11.46B |
| Date | Value |
|---|---|
| March 31, 2020 | 10.57B |
| December 31, 2019 | 10.22B |
| September 30, 2019 | 10.51B |
| June 30, 2019 | 9.891B |
| March 31, 2019 | 9.448B |
| December 31, 2018 | 9.027B |
| September 30, 2018 | 8.470B |
| June 30, 2018 | 8.488B |
| March 31, 2018 | 8.137B |
| December 31, 2017 | 8.474B |
| September 30, 2017 | 8.093B |
| June 30, 2017 | 7.576B |
| March 31, 2017 | 7.754B |
| December 31, 2016 | 7.415B |
| September 30, 2016 | 6.944B |
| June 30, 2016 | 6.822B |
| March 31, 2016 | 6.896B |
| December 31, 2015 | 6.526B |
| September 30, 2015 | 6.297B |
| June 30, 2015 | 6.303B |
| March 31, 2015 | 6.519B |
| December 31, 2014 | 5.975B |
| September 30, 2014 | 5.654B |
| June 30, 2014 | 4.962B |
| March 31, 2014 | 5.475B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AstraZeneca PLC | 66.63B |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
| Merck & Co., Inc. | 87.82B |
| Novartis AG | 80.09B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 91.00B |
| Shareholders Equity (Quarterly) | 33.84B |
| Debt to Equity Ratio | 0.6333 |
| Current Ratio | 0.8729 |
| Net Debt Paydown Yield | -0.53% |